Fact CheckerSign in

NCT01205815Recruiting

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
17 Sept 2010
Start date
3 Jun 2010
Primary completion date
Jun 2027
Lead sponsor
Vanderbilt-Ingram Cancer Center
Diseases
Melanoma
NCT number
NCT01205815

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 3 Jun 2010 to the primary completion date, Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
  • Any patient unable or unwilling to provide consent.

Who the study is looking for

  • Pathologically-proven diagnosis of melanoma.
  • Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbitl-Ingram Cancer Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.